Drugs / inactivated quadrivalent influenza vaccine (split virion)
last change Sep 2015 re-read 3 minutes ago

inactivated quadrivalent influenza vaccine (split virion)

Vaccine

Developed for
influenza
Investigated by
Jiangsu Jindike Biotechnology Co., Ltd. · Jiangsu Province Centers for Disease Control and Prevention

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02269007 May → Jul 2015 influenza Jiangsu Province Centers for Disease Control and Prevention Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as inactivated quadrivalent influenza vaccine (split virion) ClinicalTrials.gov intervention name — accepted as the source's own label NCT02269007 ↗
Modality Vaccine “Inactivated Quadrivalent Influenza Vaccine (Split Virion)” NCT02269007 ↗